Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01227642 · ClinicalTrials.gov registry record · Phase 1

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

A Phase 1 study, sponsored by Beth Israel Medical Center.

Completed
Registry status
Phase 1
Development phase
14
Enrollment target

NCT01227642 is a Phase 1 study that has completed, run by Beth Israel Medical Center. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01227642, a Phase 1 study, has completed, sponsored by Beth Israel Medical Center.

COMPLETED
Registry status
Phase 1
Development phase
14 participants
Enrollment target

Study Summary

In standard treatment, the seeds are placed throughout the prostate to treat the entire prostate. This is done because it was impossible to know where the cancer was located within the prostate. A new technique has been developed using the same ultrasound imaging that you probably had when you had your biopsy. Using this technique, areas likely to contain prostate cancer can be identified.In this early study of 15 subjects, we will test if this method to plan your prostate seed implant is safe and can be done as part of regular care. Areas identified as suspicious for cancer will be treated with higher doses of radiation while those areas not demonstrating cancer will be treated to the standard minimum dose. The higher dose areas will receive two times the minimum dose the prostate usually receives. Because this technique is not perfect, those areas not identified as cancerous should be treated in case there is a cancer area that the technique did not identify. Subjects enrolled in this study will then be followed with this ultrasound technique over the next two years to monitor the changes to the cancerous areas and will undergo a biopsy two years after the procedure. Subjects will, of course, be monitored to assess the success of the technique and its side effects.

Interventions

  • OTHER An ultrasound-based technique to identify prostate cancer
  • OTHER pre-implant transrectal ultrasound images and planning
  • OTHER ultrasound-based cancer-specific images

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2007-02
Est. Completion 2014-08
Phase Phase 1

Sponsor

Beth Israel Medical Center

44 total trials

What the Registry Record Tells You About NCT01227642

The ClinicalTrials.gov registry entry for NCT01227642 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which An ultrasound-based technique to identify prostate cancer is the first listed.

NCT01227642 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01227642 about?

NCT01227642 is a clinical study titled "Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy". In standard treatment, the seeds are placed throughout the prostate to treat the entire prostate. This is done because it was impossible to know where the cancer was located within the prostate. A new technique has been developed using the same ultrasound imaging that you probably had when you had y...

What is the current status of trial NCT01227642?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2007-02. Estimated completion is 2014-08.

What interventions are being tested in trial NCT01227642?

The interventions under investigation include: An ultrasound-based technique to identify prostate cancer (OTHER), pre-implant transrectal ultrasound images and planning (OTHER), ultrasound-based cancer-specific images (OTHER).

Who is sponsoring clinical trial NCT01227642?

This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.